ConjuGon, Inc. Raises $3.3 Million

Published: Dec 13, 2006

MADISON, WI -- (MARKET WIRE) -- December 13, 2006 -- ConjuGon, Inc., a privately held biopharmaceutical company focused on developing novel therapies for the treatment of antibiotic resistant bacterial infections, today announced it has raised a $3.3 million investment round. Rosetta Partners, a biotechnology investment group, led the financing with additional investment by the Wisconsin Investment Partners, an organized angel group.

Back to news